A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control - A randomized, multi-center, non-inferiority, phase IV clinica
| Image |  |
|---|---|
| Description | scientific article published on 29 November 2020 |
| Author/s |
author: Piotr Kuna Iwona Poziomkowska-Gęsicka Paweł Majak Maciej Kupczyk Joanna Jerzynska |
| Publication date | November 29, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |